Now available: more NGS gene panels and lower costs
Victorian Clinical Genetics Services (VCGS) has increased the number of Next Generation Sequencing (NGS) gene panels offered across several clinical areas including; neurogenetics, mitochondrial genetics and Disorders of Sex Development (DSD). These changes expand the comprehensive range of VCGS targeted panels available, offering flexible and customised options to facilitate improved diagnosis for patients.
As of 1 July 2018, targeted gene panel testing is now more cost effective, with reduced prices for most NGS panels.
VCGS is a not-for-profit subsidiary of the Murdoch Children's Research Institute and provides a fully integrated genetic testing, diagnostic and counselling service for health professionals, patients and their families. Our clinical geneticists and genetic counsellors work in close consultation with our medical scientists to provide the most accurate interpretation of complex genetic tests.
For more information about diagnostic testing or if you have any questions about our expanded panels or clinical exmoe sequencing, please email [email protected] or phone the VCGS Customer Care team on 1300 118 247.
|NGS gene panels Reduced prices||Australian Dollars|
|Upgrade to an additional panel from the same clinical area: pay the gap (if any) plus reanalysis fee||Gap ($200 if applicable) plus reanalysis fee ($350)|
|Cardiac Genetics refer to full list|
|Collagen Type II/Stickler|
|Disorders of Sex Development *New|
|Duchenne Muscular Dystrophy (full gene sequencing)|
|Emery-Dreyfus muscular dystrophy laminopathies|
|Neurogenetics *New refer to full list|
|Custom panels: 1-15 or 16-100 genes from the same clinical area|
|Mitochondrial genetic tests refer to webpage||Australian Dollars|
|Mitochondrial nuclear gene NGS panel (whole gene sequencing: POLG, SURF1) *New||$1,000|
|SURF1 variant detection: c.312_321delTCTGCCAGCCinsAT (p.Leu105Terfs)||$250|
|Whole Mitochondrial Genome analysis (suitable for blood/tissue) *New||$1,150|
|Mitochondrial DNA: targeted 22 mutations (suitable for urine)||$350|
|Targeted variant testing via Sanger sequencing is available for most diagnostic genes at $250 per variant, per patient||Australian Dollars|
|Example A (two parents): parental segregation for one variant is $250 x 2||$500|
|Example B (two parents): parental segregation for one variant is $250 x 2
NB. When the familial variant has been identified by another clinical or research laboratory, there is an additional $100 fee for curation and interpretation.
|$600 ($500 + $100 curation fee)|